home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Negative Regulator Of B Cell Function

  October, 8 2001 2:32
your information resource in human molecular genetics
Bruton's tyrosine kinase (Btk), a protein critical for B cell survival, must be tightly controlled to avoid cancer or immunodeficiency. In the October issue of Nature Immunology (Vol. 2, No. 10, Oct 01), scientists have isolated a protein that inhibits Btk activity. The discovery of this negative regulator may lead to a better understanding of immunodeficiency syndromes and the expansion of B cells, which produce antibodies to fight infections.

Various molecules that switch on Btk have been reported, but how the enzymatic activity of Btk is controlled has remained elusive. Giuseppe Scala and colleagues from Italy and the USA have identified a molecule, IBtk (inhibitor of Btk) that offers new insight into the regulation of Btk activity. By binding to a particular domain of Btk, the IBtk inhibitor protein interferes with further signal transmission and activation of cell survival genes.

Author Contact
Dr. Giuseppe Scala
University Federico II
Department of Biochemistry and Medical Biotechnologies
Via S. Pansini 5,
Naples, 80131
Telephone: 011-39-081-746-3017
Fax: 011-39-081-746 3074
Email Address: scala@dbbm.unina.it

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.